{"organizations": [], "uuid": "418cc45edac0935a8f3bdff11b515d58b9d8b719", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-7084/social", "site_section": "http://www.wsj.com/xml/rss/3_7014.xml", "section_title": "WSJ.com: US Business", "url": "https://www.wsj.com/articles/why-merck-is-betting-big-on-one-cancer-drug-1523790000", "country": "US", "domain_rank": 387, "title": "Why Merck Is Betting Big on One Cancer Drug", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-15T15:00:00.000+03:00", "replies_count": 0, "uuid": "418cc45edac0935a8f3bdff11b515d58b9d8b719"}, "author": "Peter Loftus", "url": "https://www.wsj.com/articles/why-merck-is-betting-big-on-one-cancer-drug-1523790000", "ord_in_thread": 0, "title": "Why Merck Is Betting Big on One Cancer Drug", "locations": [], "entities": {"persons": [{"name": "keytruda", "sentiment": "none"}], "locations": [{"name": "n.j.", "sentiment": "none"}, {"name": "rahway", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "merck & co.", "sentiment": "negative"}, {"name": "merck", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "RAHWAY, N.J.—Merck & Co. is making one of the biggest bets on a single drug in the pharmaceutical industry, a move that is risky but that could, if successful, pay off for the company and a broad array of cancer patients.\n\nMerck’s Keytruda, a new type of cancer drug that harnesses patients’ immune systems to fight tumors, is already marketed to treat lung, skin, bladder and other cancers. Global sales soared to more than $3.8 billion in 2017—about 9% of Merck’s total revenue—fueled by a monthly U.S. price tag of $13,500... To Read the Full Story Subscribe Sign In", "external_links": [], "published": "2018-04-15T15:00:00.000+03:00", "crawled": "2018-04-15T15:28:09.019+03:00", "highlightTitle": ""}